Search International and National Patent Collections
|1. (WO2018159845) PREVENTIVE OR THERAPEUTIC AGENT FOR HTLV-1-ASSOCIATED MYELOPATHY USING LOW-DOSE ANTI-CCR4 ANTIBODY|
|Applicants:||ST. MARIANNA UNIVERSITY SCHOOL OF MEDICINE
KYOWA HAKKO KIRIN CO., LTD.
|Title:||PREVENTIVE OR THERAPEUTIC AGENT FOR HTLV-1-ASSOCIATED MYELOPATHY USING LOW-DOSE ANTI-CCR4 ANTIBODY|
The purpose of the present invention is to provide a novel therapeutic or preventive agent for human T-cell leukemia virus-1-associated myelopathy (HAM), characterized by containing an anti-human CC-chemokine receptor 4 (CCR4) antibody or a fragment of the antibody as an active ingredient and by a dosage regimen of said antibody or of a fragment of the antibody. The present invention pertains to a therapeutic or preventative agent for HAM, which is characterized by containing an anti-human CCR4 antibody or a fragment of the antibody as an active ingredient and in that the antibody or fragment of the antibody is administered at a low dose.